Track - 1 Pharmacology : Pharmacology is the branch of biology concerned with the study of drug or medication action, where a drug can be broadly defined as any man-made, natural, or endogenous molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism.
Track-2; Psychopharmacology - Psychopharmacology is the learning of the effects of medication on the psyche (psychology), observing changed behaviours and how molecular events are manifest in a measurable behavioural form. Neuropharmacology is the study of the effects of medication on central and peripheral nervous system performance. Principles related to psychopharmacology. Neurogenesis and repair deal with other aspects on the indications for medications prescribed to address psychiatric and behavioural problems, that are associated with, including antipsychotic, anxiolytic and anticonvulsant medications, acquired brain injury and Neurocognitive effects associated with therapeutic drugs also include mood stabilizers and treatments prescribed for disorders of attention. The treatments may cause side effects such as induction of the metabolic syndrome, type-2 diabetes related to the medications prescribed for management of psychiatric and behavioural disorders and disturbances. Ethno psychopharmacology also deals with the biotransformation and metabolism of medications, as well as specific differential actions: i.e., CYP450 enzymatic inhibition and induction of metabolism of psychopharmacological and herbaceutical substrates.
Track-3 : Clinical Pharmacology has been practiced for centuries through observing the effects of herbal remedies and early drugs on humans. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. Pharmacokinetic and pharmacodynamic parameters become important because of the association between host drug concentrations, microorganism eradication, and resistance. Since long scientific advances allowed scientists to come together with the study of physiological effects with biological effects Receptor theory for drug effects and its discovery with clinical pharmacology has stretched out to be a multidisciplinary field and has contributed to the findings of drug interaction, therapeutic effectiveness and safety. Drug interactions and pharmacological compatibilities include the study of pharmacokinetics that includes the absorption, distribution, metabolism, and elimination of drugs. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. Pharmacokinetic and pharmacodynamic parameters become especially important because of the association between drug application, microorganism abolition and resistance.
Pharmacodynamics& Pharmacokinetics - Pharmacodynamics (PD) is the study of the biochemical and physiologic effects of drugs (especially pharmaceutical drugs). Pharmacokinetics is the study of how the organism affects the drug.
Trcak 5: Cardiovascular Pharmacology: Cardiovascular Pharmacology Concepts basically deals with the drugs that are used in the treatment of cardiovascular disease.
These are the Examples of drugs in this class include chlorothiazide, amiloride, furosemide, bumetanide, indapamide and spironolactone. Vasodilators - These drugs relax the blood vessels and cause blood pressure to fall.
Track 6: Ethnopharmacology: Ethnopharmacology- focuses on the use of traditional medicine in local communities, including its commercial applications. We welcome field studies, pharmacological and clinical studies of chemically profiled extracts, and studies on the quality and composition of naturally derived products.
Track 7: Immunopharmacology- Immunopharmacology The science of immunopharmacology aims to manipulate the immune system by modifying the endogenous immune responses to the benefit of the host in the treatment of diseases.
Track 8: Pharmacogenetics and Pharmacogenomics -Pharmacogenetics and Pharmacogenomics explores the role of genetic variation in the effects of drugs and xenobiotic substances on the body, and in the body’s reactions to drugs — publishing basic, translational, and pharmaceutical research.
Track 9: Toxicology : Toxicology- is a scientific discipline, overlapping with biology, chemistry, pharmacology, and medicine, that involves the study of the adverse effects of chemical substances on living organisms and the practice of diagnosing and treating exposures to toxins and toxicants.
Track 10 : Computer-aided drug design (CADD)- Computer-aided drug desig is an exciting and diverse discipline where various aspects of applied and basic research merge and stimulate each other. In the early stage of a drug discovery process, researchers may be faced with little or no structure activity relationship (SAR) information.
Track 11: Biomarkers in Drug Design- Robust and validated biomarkers are needed to improve diagnosis, monitor drug activity and therapeutic response and guide the development of safer and targeted therapies for various chronic diseases. While different types of biomarkers have been impactful in the field of drug discovery and development, the process of identifying and validating disease specific biomarkers has been quite challenging. Recent advances in multiple ‘omics’ (multi-omics) approaches (e.g., genomics, transcriptomics, proteomics, metabolomics, cytometry and imaging) in combination with bioinformatics and biostatistics have made it possible to accelerate the discovery and development of specific biomarkers for complex chronic diseases.
Track 12: Pre-Formulation & Formulation Aspects- Drug Formulation is the discipline of connections between pre formulation, pharmaceutical formulation, delivery, disposition and clinical response. The intrinsic instability nature of a new drug will change its preferred form into unwanted form when presented in a appropriate dosage form with the excipients upon storage.Recently this process confnded only for determining limited traits, but today this process is being considered as a formulation strategy and hence tremendous technological advancement has been accomplished in this arena which enables us to save time and money via planned management system and hence influence Drug Formulation 2017. Pre formaulation and optimization process becomes more easier by using statistical softwatre and neural netowrking system . Role of pre formulation techniques like freeze drying aspects projects the event Drug Formulation 2017 to pose as a freeze drying meeting in drug discovery, drug development plays a cognizant role in development and the revisions will help in various dosage forms design.
Track 13: Innovative Drug Discovery and Nanotechnology: Innovative Drug Discovery and Nanotechnology is a fundamental unit operation having cognizant disciplines in pharmacy. It supports in improving solubility and bioavailability,limiting toxicity, enhancing release and providing better formulation opportunities for drugs.Mostly size reduction is confined to micron size range, for insance, pharmaceutical dosage forms like powder, emulsion, suspension etc.Nano meter size range drugs emend performance of dosage forms. Substantial merits of nanosizing include :
(i) increased surface area,
(ii) enhanced solubility,
(iii) increased rate of dissolution,
(iv) increased oral bioavailability,
(v) more rapid onset of therapeutic action,
(vi) less amount of dose required,
(vii) decreased fed/fasted variability,
(viii) decreased patient-to-patient variability.
Track 14: Novel Drug delivery System (NDDS)- deals to the formulations systems and technologies for carrying a pharmaceutical compound in the body as it is essential to safely achieve its desired therapeutic effects. Drug delivery systems (DDS),works on interdisciplinary prinicples which combines pharmaceutics, bio conjugate chemistry, and molecular biology,
Track 15: Medicinal Chemistry and Drug Discover Advancements-Medicinal Chemistry is an arm of chemistry which especially deals with synthetic organic chemistry and pharmacology comprising various biological expertization which is involved with design, chemical reaction and development of drug for marketing of pharmaceutical agents. It combines knowledge and capacities comprising fields of cheminformatics, molecular modeling and cognizant bioinformatics. Now a days a Medicinal chemist requires knowledge and better understanding to get a clear mechanism of drug design.
Track 17: Liposomes and nanoparticles: Nanoscale drug delivery systems using liposomes and nanoparticles and these are emerging technologies for the targeted delivery of chemotherapeutic drugs in the treatment of hetrogenous ailments. Nanoparticles confer possible dangers, both medically and environmentally.Undergoing research conducted with prescription drugs, vaccines, and OTC drugs directly influnced the Pharma industry. Clinical trials ensures that products being developed are tested or examined on how individuals affected by the diseases or conditions they are producing to treat.
Track 17: Ocular Pharmacology- Eye has many varied layers and structures responsible to prevent the eye from things that could damage it. This unique structure,has been a hurdle for medicine to develop drugs effective in treating different eye conditions. The different administration routes that are used to treat the eye include topical, systemic, and periocular. Let's take a closer look at each at the stage of Pharma Congress.
Track 19: Biochemical pharmacology- deals with the effects of drugs on biochemical pathways underlying the pharmacokinetic and pharmacodynamic mechanisms and the subsequent therapeutic and the toxicological process.
Track-20: Pharmaco epidemiology and Pharmaco-Economics -Pharmacoepidemiology is a sub-instruction of epidemiology which concerned with determining the efficacy, effectiveness and safety of pharmaceutical commmodity while Pharmacoeconomics is study of health economics which spotlight the examination of pharmaceutical commodity with regards the value for money.
On large scale it seems that the objective of pharmacoepidemiology and pharmacoeconomics are homogenous of evaluating pharmaceuticals products but in deep analysis these streams works parallely. Practitioners of each domain work largely in sepration of each other, while the proof logic which seems true in one may also contradict the other.
Track 21: Pharmacological Testing: Development of medication is a Key concern to medicine. The metabolic stability and the reactivity of a drug compounds have to be analysed for drug metabolism and toxicological studies. various methods of pharmacological tests have been proposed for quantitative prognosis in drug metabolism.
pharmaceutical market affected at a large scale through laws and regulations but maintaining continuous growth as the diagnosis and understanding of diseases and condition has emerged and improved. BCC Research report’s cover the recent pharmaceutical market and provide deep market analysis, predictions, trends, patent analysis, and profiles of major players within the markets. An encyclopedic analysis for biopharmaceuticals, elimination and treatment of definite cancers, coagulants and non-coagulants all are within the range of pharmaceutical markets.
Track 22: Drug Product Manufacturing-The drug product manufacturing facility is designed to create injectable in syringes or vials in Grade A environment. Industries fights to improve commodity quality in today’s competitive environment and as well minimize the production cost.
Track 23: Pharmaceutical Regulatory - Pharmaceutical Regulatory Affairs is a discipline in a pharma company which ensures that organization complying all the regulations and laws concerning to drug research and development companies. This department works with federal, state and local regulatory agencies on matter of affecting drug research and development.
Track 24: Recent advancements in BA/BE Research - The Objective of bioavailability study is to find out the dosage form effecting on the biological performance of the drug, sensitivity to identify differences in the rate and extent of absorption. Bioavailability and bioequivalence branch design comprises Single dose or multi dose standard 2x 2 crossovers, Parallel groups, for more than two formulations. Study design refers the approximation essential pharmacokinetic parameters differs significantly from a bioequivalence study meant for comparing the test formulation. The results of this discipline can be used as the sole basis to document BA or BE provided the study’s design and execution are satisfactory and enough subjects have completed the study
Track 25: Business Opportunities in Drug Delivery-The global market for Business Development of Drug Delivery Technology in 2010 was $131.6 billion and assumed to rise at a compound annual growth rate (CAGR) of 5% and targeted nearly $175.6 billion by 2016. The U.S comprise approximately 59% of the total drug delivery market in 2010 and was $78 billion. Its prediction to target nearly $103 billion in 2016 at a CAGR of 4.7%. Europe contributed about 27% of the total drug delivery market in 2010 and was $36 billion and it is assumed to grow to $49 billion by 2016 at a CAGR of 5.6% in 2013, according to BCC research Drug Delivery Global market reached $150.3 billion.This was an increase from $142 billion the previous year. Given its forecasted annual growth the market reflects a considerable business opportunity, which has been representing in increasing number of drug delivery specialists. Consistent quality and competitive costs of commodity improves Production performance and continuity of supply and Product and technology auditing and due diligence with minimizing Regulatory Issues, quality control, and business development Business opportunities in drug delivery.
Track 26: NMR and Analysis of Small Organic Molecules- In bioscience and drugs, to small size molecule may be a coffee mass (<900 Daltons) compound which is not capable to accelerate a process, with a size order of 10−9 m. Most drug analysis square assess identical little molecules. For examination of small organic molecules the subsequent devices care to be recycled are as given :HPLC method, Chromatography, Ultraviolet-visible (UV-VIS) spectrophotometry, Infrared (IR) spectrometry and Mass spectrometry.
Track 27: Pharmaceutical Sciences -Pharmaceutical Sciences is a changing and interdisciplinary discipline that aims to integrate fundamental postulates of physical and organic chemistry, engineering, biochemistry, and biology to clarify how to enhance delivery of drugs to the body and translate this integrated understanding into new and improved therapies.
Track 28: Pharma and Biotech Financial Outlook -Since from past few years for both the pharmaceutical and biotechnology industries had a positive aspects. Most importantly, there has been a renaissance with respect to the increase in the number of new drugs approved and under development for the two branches of the business.
Innovations are driven by new research methods and the growth of new therapeutic options, such as immune-related oncology drugs, personalized medicine, stem cells, and biologics. We are also witnessing the development of a higher number of drugs that prevents diseases rather than just extend life.
Track 29: Bio Pharmaceuticals -A biopharmaceutical, also called as a biologica or medical product, or biologic term refers that is any pharmaceutical drug commodity isolated from, or semisynthesized from biological sources. Different from amalgameted pharmaceuticals, they comprise vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells. There precursors are extracted from living sources—human, animal, plant, fungal, or microbial.
Track 30: Importance of Audit in Pharmaceutical Industry-International Organization for Standardization (ISO) 9000 requirements do not have the similiar status of “the law” in the U.S. as do requirements listed in the Code of Federal Regulations. Because 21 CFR 210 and 211 have legal status, the U.S. Justice Department has external powers to ensure compliance. For instance, product in the marketplace can be seized, fines can be levied, and personal liability can be assigned. So, management must understand that auditing must be taken seriously and sincerely, and the requirements listed are just that requirements they has to be taken serious.While audits are the common place in the pharmaceutical industry, the preparedness for those events varies.
Track 31: The Active Pharmaceutical Ingredient (API) - The Active Pharmaceutical Ingredient (API) is the part of any drug which produces its effects. Some drugs, such as combined therapies, has several active ingredients to treat various symptoms & act in varied ways.Production of APIs has traditionally been done by the pharmaceutical companies themselves in their own countries. But in recent years many oranizations have opted to send producing overseas to cut costs. This has caused important changes to how these drugs are regulated, with more effective guidelines and inspections kept into place.
Track 32: Advancements In Pharmaceutical Biotechnology-The term is Pharmaceutical Biotechnology is the study of science that deals with all the technologies required for producing and registering of biological drugs. Pharmaceutical Biotechnology is a highly demanded area of science and technology. The Pharmaceutical Biotechnology covers a wide area ranging from multiple ethical issues to changes in healthcare arena and a significant efforts to the development of the national economy. Biotech drugs mainly use those microorganisms as components in medications to prevention from various diseases and conditions, from cancer to rheumatoid arthritis to multiple sclerosis.